Alleged Drug Allergies in Military General Medicine: Patients' Experiences and Beliefs

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-28

Study Completion Date

2024-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study focuses on the experience of the military patient reporting a suspected drug allergy, with its own specificities. Suspicions of drug allergies during a mission expose the doctor to difficulties.

This study will improve understanding of the allergy patient's point of view. The end result could be a set of ideas for measures to raise awareness among these patients, and motivate them to undergo an allergological assessment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Allergy Testing of Soldiers Prepared for International Mission

NCT05807958

Adult Military Personnel

COMPLETED NA

Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment

NCT01520181

Beta-lactam Allergy

COMPLETED NA

Wheal and Flare Reaction During 24 Hours in Allergic Volunteers.

NCT00521170

Allergy

COMPLETED PHASE1

Interest of the Second Phase of the Oral Challenge Test in Patients With Suspected Long-standing Penicillin Allergy

NCT04513938

Allergy Penicillin

COMPLETED

Management of Drug Hypersensitivity in Children

NCT02031120

Drug Hypersensitivity

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Allergy Penicillin

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interview

Monocentric qualitative study with a descriptive socio-demographic section, a descriptive qualitative section on the experience and perception of allergy, then on the obstacles to allergological assessment, and finally a descriptive quantitative section to evaluate knowledge of antibiotic therapy.

Interview

Intervention Type OTHER

Semi-structured interview on experiences, perceptions, beliefs and knowledge of drug allergy and barriers to allergological testing, with a view to content analysis.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Interview

Semi-structured interview on experiences, perceptions, beliefs and knowledge of drug allergy and barriers to allergological testing, with a view to content analysis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Military personnel (active or reservist)
* Reporting a drug allergy during a periodic medical check-up or during a consultation in a medical unit
* Not opposed to participating in the study.

Exclusion Criteria

* Candidate on admission visit
* Opposition to study
* Minor (under 18 years of age)
* Pregnant, parturient or breast-feeding woman
* Person deprived of liberty by a judicial or administrative decision, person under psychiatric care
* Non-French nationals
* Person of full age subject to a legal protection measure
* Person unable to express non-opposition

Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes